Esmya (ulipristal acetate) - Important Safety Information from Gedeon Richter Plc. as approved by the HPRA (August 2018)

Notice type: 3rd Party Publications

Date: 10/08/2018

Important Safety Information communication from Gedeon Richter Plc. on new contraindication, requirements for liver monitoring and restricted indication for Esmya (ulipristal acetate).

Important Safety Information - Esmya (ulipristal acetate), August 2018